Astellas Gets Japanese Prograf Approval For PM/DM Interstitial Pneumonia
This article was originally published in PharmAsia News
Executive Summary
Astellas’ immunosuppressant Prograf received approval in Japan for the additional indication of interstitial pneumonia associated with polymyositis and dermatomyositis.